Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy P Mendenhall

Showing results (31-40 of 165) with videos related to

Pageof 17
Sort By:
International Journal of Particle Therapy|November 28, 2019
Mesenchymal ChondrosarcomaWilliam M Mendenhall, John D Reith, Mark T Scarborough, et al.
International Journal of Particle Therapy|May 1, 2026
Robust Four-Field and Arc LET-Optimized Proton Prostate Cancer Treatment Plans With Urethral SparingMichael Vieceli, Jiyeon Park, Mo Saki, et al.
American Journal of Clinical Oncology|April 2, 2005
A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphomaBradley J G Larson, John M Waples, Annette Pusateri, et al.
American Journal of Clinical Oncology|February 8, 2006
Giant cell tumor of boneWilliam M Mendenhall, Robert A Zlotecki, Mark T Scarborough, et al.
American Journal of Clinical Oncology|May 13, 2009
Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ringDaniel T Chang, Nancy P Mendenhall, James W Lynch, et al.
American Journal of Clinical Oncology|August 7, 2009
Erectile dysfunction after radiotherapy for prostate cancerWilliam M Mendenhall, Randal H Henderson, Daniel J Indelicato, et al.
Clinical and Translational Science|August 11, 2021
What men want: Results from a national survey on decision making for prostate cancer treatment and research participationNancy P Mendenhall, Sarah M Rausch Osian, Curtis M Bryant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2005
Phase II trial of individualized rituximab dosing for patients with CD20-positive lymphoproliferative disordersLucio N Gordan, William B Grow, Annette Pusateri, et al.
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Consolidative Proton Therapy Following High-dose Chemotherapy and Autologous Stem Cell Transplant in an Adolescent with Relapsed Hodgkin LymphomaNicholas B Figura, Stella Flampouri, Keri Hopper, et al.
Oncology (Williston Park, N.Y.)|June 27, 2012
Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapyBradford S Hoppe, Stella Flampouri, James Lynch, et al.
Pageof 17

Showing results (31-40 of 165) with videos related to

Sort By:
Pageof 17
International Journal of Particle Therapy|November 28, 2019
Mesenchymal ChondrosarcomaWilliam M Mendenhall, John D Reith, Mark T Scarborough, et al.
International Journal of Particle Therapy|May 1, 2026
Robust Four-Field and Arc LET-Optimized Proton Prostate Cancer Treatment Plans With Urethral SparingMichael Vieceli, Jiyeon Park, Mo Saki, et al.
American Journal of Clinical Oncology|April 2, 2005
A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphomaBradley J G Larson, John M Waples, Annette Pusateri, et al.
American Journal of Clinical Oncology|February 8, 2006
Giant cell tumor of boneWilliam M Mendenhall, Robert A Zlotecki, Mark T Scarborough, et al.
American Journal of Clinical Oncology|May 13, 2009
Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ringDaniel T Chang, Nancy P Mendenhall, James W Lynch, et al.
American Journal of Clinical Oncology|August 7, 2009
Erectile dysfunction after radiotherapy for prostate cancerWilliam M Mendenhall, Randal H Henderson, Daniel J Indelicato, et al.
Clinical and Translational Science|August 11, 2021
What men want: Results from a national survey on decision making for prostate cancer treatment and research participationNancy P Mendenhall, Sarah M Rausch Osian, Curtis M Bryant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2005
Phase II trial of individualized rituximab dosing for patients with CD20-positive lymphoproliferative disordersLucio N Gordan, William B Grow, Annette Pusateri, et al.
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Consolidative Proton Therapy Following High-dose Chemotherapy and Autologous Stem Cell Transplant in an Adolescent with Relapsed Hodgkin LymphomaNicholas B Figura, Stella Flampouri, Keri Hopper, et al.
Oncology (Williston Park, N.Y.)|June 27, 2012
Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapyBradford S Hoppe, Stella Flampouri, James Lynch, et al.
Pageof 17